Form 4: Korro Bio COO Sells Shares for Tax Withholding

Korro Bio's Chief Operating Officer, Todd Chappell, reported a transaction involving the sale of 3,168 shares of common stock to cover tax obligations upon the vesting of restricted stock units.

Summary

• Todd Chappell, Chief Operating Officer of Korro Bio, Inc., reported a transaction on June 16, 2026.
• The transaction involved the sale of 3,168 shares of common stock.
• These shares were sold to satisfy mandatory tax withholding obligations incurred upon the vesting and settlement of restricted stock units (RSUs).
• The sale occurred at a weighted-average price of $10.83 per share, with individual sales ranging from $10.58 to $11.35.
• Following this transaction, Chappell beneficially owns 16,964 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale of shares is a standard procedure for covering tax obligations related to equity compensation and does not reflect a change in the reporting person's investment thesis.

Positives

• The transaction was a mandatory sale to cover tax obligations, indicating a normal course of business for equity compensation.
• The reporting person continues to hold a significant number of shares (16,964) after the sale.

Negatives

• A portion of the company's stock was sold, which could be perceived negatively by the market if not understood as a tax-related event.

Risks

• The filing does not explicitly mention any new risks. However, the sale of shares by an insider, even for tax purposes, can sometimes be interpreted as a lack of confidence by the market, although this is a standard procedure for RSUs.

Future Outlook

The filing indicates that 10,066 shares are expected to vest on December 15, 2026, subject to continued service, suggesting ongoing equity compensation arrangements.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding upon RSU vesting are a common and expected event in the biotechnology and technology sectors, where equity-based compensation is prevalent. This type of transaction is typically not indicative of a change in management's outlook on the company's performance.

Stakeholder Impact

• Shareholders: The sale is a routine tax event and not expected to significantly impact the share price. However, any insider selling can create minor downward pressure if not understood in context.
• Employees: This transaction is a standard part of the company's equity compensation plan for executives.
• Management: The transaction fulfills tax obligations related to executive compensation.

Next Steps

• Monitoring the vesting of the remaining 10,066 RSU shares on December 15, 2026.

Key Dates

Keywords

Korro Bio, KRRO, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Tax Withholding, Chief Operating Officer, Beneficial Ownership